Enzyme-multiplied immunoassay (EMIT 2000) digoxin assay compared with fluorescence polarization immunoassay and amerlex 125I-radioimmunoassay at two Australian centers

Therapeutic Drug Monitoring

Volumn 18, Issue 6, 1996, Pages 672-677

  Saccoia, N C ^a   Hackett, L P ^b   Morris, R G ^a   Ilett, K F ^b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Digoxin; Digoxin like immunoreactive substances; Immunoassay; Therapeutic drug monitoring

Indexed keywords

DIGITALIS LIKE FACTOR; DIGOXIN; IODINE 125;

ACCURACY; ARTICLE; AUSTRALIA; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; INTERMETHOD COMPARISON; NEWBORN; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

ANTI-ARRHYTHMIA AGENTS; CARDENOLIDES; CARDIOTONIC AGENTS; CROSS REACTIONS; DIGOXIN; DRUG MONITORING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FETAL BLOOD; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SAPONINS;

EID: 0029826649     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199612000-00008     Document Type: Article

References (21)

1. Redfors A. Plasma digoxin concentrations: its relation to digoxin dosage and clinical effects in patients with atrial fibrillation. Br Heart J 1972;34:383-91.
2. Valdes R Jr. Improving the specificity of digoxin immunoassays [Review]. Wien Klin Wochenschr 1994;suppl 1992 (191):55-9.
3. Fushimi R, Amino N. Digoxin concentration in blood [Abstract]. Jpn J Clin Pathol 1995;43:34-40.
4. Pudek MR, Seccombe DW, Jacobson BE, Whitfield MF. Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. Clin Chem 1983;29:1972-4.
5. Morris RG, Frewin DB, Saccoia NC, Goldsworthy WL, Jeffries WS, McPhee AJ. Interference from digoxin-like immunoreactive substance(s) in commercial digoxin kit methods. Eur J Clin Pharmacol 1990;39:359-63.
6. Schelbusch H. Endogenous digoxin-like immunoreactive factors (DLIF) as measured by the CEDIA digoxin assay and fluorescence polarisation immunoassay. Wien Klin Wochenschr 1994;suppl 1992(191):59-66.
7. Dodds HM, Norris RL, Johnson AG, Pond SM. Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays. Ther Drug Monit 1995;17:68-74.
8. Graves SW, Sharma K, Chandler AB. Methods for eliminating interferences in digoxin immunoassays caused by digoxin-like factors. Clin Chem 1986;32:1506-9.
9. Ray JE, Crisan D, Howrie DL. Digoxin-like immunoreactivity in serum from neonates and infants reduced by centrifugal ultrafiltration and fluorescence polarization immunoassay. Clin Chem 1991;37:94-8.
10. Qazzaz HM, Goudy S, Miller JJ, Valdes R Jr. Treatment of human serum with sulfosalicyclic acid structurally alters digoxin and endogenous digoxin-like immunoreactive factor. Ther Drug Monit 1995;17:53-9.
11. Wahyono D, Piechaczyk M, Scherrmann JM, et al. Highly specific radioimmunoassay for digoxin using a monoclonal antibody selected for lack of interference by digoxin-like immunoreactive substances in cord blood sera. Ther Drug Monit 1991;13:113-9.
12. Lucena MI, Andrade RJ, Fraile JM, Alcantara R, Gonzalez-Correa FS. Endogenous digoxin-like substance in liver failure. Int J Clin Pharmacol Ther 1994;32:567-9.
13. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:308-10.
14. Morris RG, Frewin DB, Taylor WB, Glistak ML, Lehmann DR. The effect of renal and hepatic impairment and of spironolactone on digoxin assays. Eur J Clin Pharmacol 1988; 34:233-9.
15. Durakovic Z, Ivanonic D, Durakovic A. Digoxin-like substances in the serum of uremic patients before and after hemodialysis. Cardiovasc Drug Ther 1989;2:757-60.
16. Graves SW, Brown B, Valdes R. An endogenous digoxin-like substance in patients with renal impairment. Ann Intern Med 1983;99:604-8.
17. Nanji AA, Greenway DC. Falsely raised digoxin concentrations in liver disease. Br Med J 1985;290:423-33.
18. Valdes R, Graves SW, Brown BA, Landt M. Endogenous substance in newborn infants causing false positive digoxin measurements. J Pediatr 1983;102:947-50.
19. Hicks JM, Brett EM. Falsely increased digoxin concentrations in samples from neonates and infants. Ther Drug Monit 1984;6:461-4.
20. Pleasants RA, Williams DM, Porter RS, Gadsen RH Sr. Reassessment of cross-reactivity of spironolactone metabolites with four digoxin immunoassays. Ther Drug Monit 1989;11: 200-4.
21. Jiang F, Wilhite TR, Smith CH, Landt M. A new digoxin immunoassay substantially free of interference by digoxin immunoreactive factor. Ther Drug Monit 1995;17:184-8.